Publications

Journal Article
Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Epublish 71 citations
Electronic publication date
February 26, 2020

View on Pubmed.gov 31501273 | View on doi.org 10.1128/MCB.001...

MicroRNA 7 Impairs Insulin Signaling and Regulates Aβ Levels through Posttranscriptional Regulation of the Insulin Receptor Substrate 2, Insulin Receptor, Insulin-Degrading Enzyme, and Liver X Receptor Pathway.

Search for publications in this journal Mol Cell Biol

Abstract

Brain insulin resistance is a key pathological feature contributing to obesity, diabetes, and neurodegenerative disorders, including Alzheimer's disease (AD). Besides the classic transcriptional mechanism mediated by hormones, posttranscriptional regulation has recently been shown to regulate a number of signaling pathways that could lead to metabolic diseases. Here, we show that microRNA 7 (miR-7), an abundant microRNA in the brain, targets insulin receptor (INSR), insulin receptor substrate 2 (IRS-2), and insulin-degrading enzyme (IDE), key regulators of insulin homeostatic functions in the central nervous system (CNS) and the pathology of AD. In this study, we found that insulin and liver X receptor (LXR) activators promote the expression of the intronic miR-7-1 and , along with its host heterogeneous nuclear ribonucleoprotein K (HNRNPK) gene, encoding an RNA binding protein (RBP) that is involved in insulin action at the posttranscriptional level. Our data show that miR-7 expression is altered in the brains of diet-induced obese mice. Moreover, we found that the levels of miR-7 are also elevated in brains of AD patients; this inversely correlates with the expression of its target genes IRS-2 and IDE. Furthermore, overexpression of miR-7 increased the levels of extracellular Aβ in neuronal cells and impaired the clearance of extracellular Aβ by microglial cells. Taken together, these results represent a novel branch of insulin action through the HNRNPK-miR-7 axis and highlight the possible implication of these posttranscriptional regulators in a range of diseases underlying metabolic dysregulation in the brain, from diabetes to Alzheimer's disease.

References

Genes Dev. 2013 Jan 1;27(1):24-38

Arch Neurol. 2012 Jan;69(1):29-38

J Neurochem. 2006 Aug;98(3):792-800

J Angiogenes Res. 2010 Jun 08;2(1):9

Cited by 71 citations (total)

Journal Article Review

Extracellular Vesicles Loaded miRNAs as Potential Modulators Shared Between Glioblastoma, and Parkinson's and Alzheimer's Diseases.

Electronic publication date December 18, 2020

Search for publications in this journal Front Cell Neurosci

Laura Thomas [...] Carolina Perez-Castro et al.

Glioblastoma (GBM) is the deadliest brain tumor. Its poor prognosis is due to cell heterogeneity, invasiveness, and high vascularization that...

Journal Article Research Support, Non-U.S. Gov't Review

Mechanisms Driving Palmitate-Mediated Neuronal Dysregulation in the Hypothalamus.

Electronic publication date December 24, 2021

Search for publications in this journal Cells

Calvin V Lieu [...] Denise D Belsham et al.

The hypothalamus maintains whole-body homeostasis by integrating information from circulating hormones, nutrients and signaling molecules. Distinct neuronal subpopulations that express...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances

Copyright

Copyright © 2019 American Society for Microbiology.